| October 11, 2017 |
| New Developments |
| America’s Opioid Epidemic: Who Will Be Held Accountable? By Ally Schwab In recent years America has seen an increasing number of opioid-involved deaths and is currently experiencing what the Center for Disease Control (“CDC”) describes as an “opioid epidemic.” This crisis has been devastating to many communities and individuals, and |
…
The United States Supreme Court recently narrowed the scope of both specific and general jurisdiction in two seminal cases, Bristol-Myers Squib Co. v. Superior Court of California, San Francisco County, 137 S.Ct. 1773 (2017) and BNSF Railway Co. v. Tyrrell, 137 S.Ct 1549 (2017).
| December 13, 2016 |
| New Developments |
| Auto Manufacturers Partner with Nauto to Improve Driverless Car Technology By Shannon Peters One of the main obstacles to the autonomous vehicle industry is “infrastructure,” but not in the sense typically associated with the term. Since autonomous vehicles come in all shapes, sizes, and powertrain types (gasoline, electric, and hybrid), |
…
| October 7, 2016 |
| New Developments |
| The Duty to Warn in New York By Dan Jaffe New York’s highest court recently held in two asbestos cases (Dummit v. A. W. Chesterton and Suttner v. A. W. Chesterton) that a manufacturer of valves had a duty to warn of the hazards arising from the use of its |
…
| September 12, 2016 |
| New Developments |
| FDA Requires Highest Level of Warning on Opioids & Benzodiazepines By Jenna Marie Stupar On August 31, 2016 the Food and Drug Administration (FDA) issued a new directive to include the “black box” label on approximately 400 opioid and benzodiazepine products. Opioids are powerful pain reducing medications including prescription oxycodone, |
…
| September 2, 2016 |
| New Developments |
| Toward a Defense of Mesothelioma Cases on Causation: Low Doses and Genetics By Mark Zellmer Today’s defendants in asbestos litigation often face plaintiffs’ claims that they have contracted mesothelioma from exposure to low or even doubtful doses of asbestos. If the mesothelioma looks to be spontaneous (idiopathic) or the result |
…
